Join
Live feed
·
PRReleasevia Quantisnow
Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Announces Interim OTC Deficiency Phase 2 Results and Introduces LUNAR 2.0™ Next-Generation mRNA Delivery Platform

ByQuantisnow·Wall Street's wire, on your screen.
ARCT· Arcturus Therapeutics Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARCT (Arcturus Therapeutics Holdings Inc.) and more on Quantisnow.